Question 1

Does Balyasny Asset Management own RLMD stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Balyasny Asset Management holds 1,520,688 shares of RLMD (Relmada Therapeutics), worth $10.5M.

Question 2

How many shares of RLMD does Balyasny Asset Management own?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management holds 1,520,688 shares of RLMD (Relmada Therapeutics).

Question 3

What is Balyasny Asset Management's RLMD position worth?

Accepted Answer

As of its Q2 2026 13F, Balyasny Asset Management's RLMD position is worth $10.5M.

Question 4

Is Balyasny Asset Management buying or selling RLMD?

Accepted Answer

In Q2 2026, Balyasny Asset Management increased its RLMD position from 252,457 to 1,520,688 shares.

Question 5

When did Balyasny Asset Management first buy RLMD?

Accepted Answer

Balyasny Asset Management first reported RLMD in its Q2 2022 13F and has listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.5M	+502.4%	$10.5M	0.0%	$6.92	45
2026-Q1	Decreased	252,457	-53.9%	$1.8M	0.0%	$4.67	0
2025-Q4	New	547,854	-	$2.6M	0.0%	$4.53	36
2024-Q2	Exited	0	-100.0%	$0	0.0%	$3.00	0
2024-Q1	New	12,322	-	$57,297	0.0%	$4.65	29
2022-Q4	Exited	0	-100.0%	$0	0.0%	$3.49	0
2022-Q3	Increased	307,314	+28.8%	$11.4M	0.0%	$36.19	35
2022-Q2	New	238,521	-	$4.5M	0.0%	$19.34	37

RLMD8 quarters

RLMD
8 quarters